 Fen Xia
Concepts (110)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Repair | 6 | 2025 | 197 | 2.750 |
Why?
| | Sirtuin 2 | 3 | 2026 | 15 | 2.250 |
Why?
| | Cisplatin | 4 | 2021 | 282 | 1.870 |
Why?
| | DNA Breaks, Double-Stranded | 4 | 2026 | 76 | 1.830 |
Why?
| | Peripheral Nervous System Diseases | 2 | 2021 | 60 | 1.270 |
Why?
| | BRCA1 Protein | 2 | 2025 | 39 | 1.050 |
Why?
| | Neurons | 2 | 2020 | 394 | 1.040 |
Why?
| | Recombinational DNA Repair | 1 | 2026 | 14 | 0.950 |
Why?
| | Stomatitis | 1 | 2026 | 19 | 0.950 |
Why?
| | DNA End-Joining Repair | 1 | 2025 | 18 | 0.940 |
Why?
| | Radiation Injuries | 1 | 2026 | 114 | 0.860 |
Why?
| | Brain Neoplasms | 2 | 2025 | 319 | 0.750 |
Why?
| | Cell Line, Tumor | 6 | 2026 | 1470 | 0.710 |
Why?
| | Carrier Proteins | 2 | 2025 | 315 | 0.710 |
Why?
| | Immunomodulation | 1 | 2021 | 36 | 0.680 |
Why?
| | Glioblastoma | 1 | 2022 | 101 | 0.680 |
Why?
| | Melanoma | 2 | 2021 | 277 | 0.670 |
Why?
| | Killer Cells, Natural | 1 | 2021 | 113 | 0.660 |
Why?
| | Aniline Compounds | 1 | 2020 | 48 | 0.630 |
Why?
| | Sulfonamides | 1 | 2020 | 139 | 0.600 |
Why?
| | Gene Regulatory Networks | 1 | 2020 | 112 | 0.590 |
Why?
| | Thyroid Hormones | 1 | 2018 | 23 | 0.570 |
Why?
| | Animals | 11 | 2026 | 13526 | 0.570 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2021 | 350 | 0.570 |
Why?
| | Mice | 7 | 2026 | 5982 | 0.550 |
Why?
| | Radiosurgery | 3 | 2025 | 133 | 0.530 |
Why?
| | Rad51 Recombinase | 3 | 2025 | 29 | 0.500 |
Why?
| | Benzimidazoles | 1 | 2017 | 50 | 0.500 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2017 | 56 | 0.500 |
Why?
| | Membrane Proteins | 1 | 2018 | 333 | 0.490 |
Why?
| | Triazoles | 1 | 2017 | 114 | 0.480 |
Why?
| | Radiotherapy, Intensity-Modulated | 3 | 2025 | 181 | 0.480 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2017 | 122 | 0.480 |
Why?
| | Antineoplastic Agents | 3 | 2021 | 1232 | 0.460 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1112 | 0.440 |
Why?
| | Alzheimer Disease | 1 | 2018 | 338 | 0.420 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 3 | 2025 | 250 | 0.350 |
Why?
| | Obesity | 1 | 2018 | 1204 | 0.300 |
Why?
| | Telomere-Binding Proteins | 1 | 2025 | 9 | 0.240 |
Why?
| | Humans | 13 | 2026 | 53230 | 0.240 |
Why?
| | Mouth Mucosa | 1 | 2026 | 27 | 0.240 |
Why?
| | Homologous Recombination | 1 | 2026 | 45 | 0.230 |
Why?
| | Endodeoxyribonucleases | 1 | 2025 | 47 | 0.230 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 1925 | 0.230 |
Why?
| | Neuroma, Acoustic | 1 | 2025 | 22 | 0.230 |
Why?
| | Stem Cells | 1 | 2026 | 189 | 0.210 |
Why?
| | Epithelial Cells | 1 | 2026 | 218 | 0.210 |
Why?
| | Phosphorylation | 1 | 2025 | 533 | 0.210 |
Why?
| | Nuclear Proteins | 1 | 2025 | 250 | 0.210 |
Why?
| | Radiation Oncology | 1 | 2023 | 26 | 0.200 |
Why?
| | Female | 6 | 2025 | 28782 | 0.200 |
Why?
| | Organs at Risk | 2 | 2025 | 71 | 0.190 |
Why?
| | Head and Neck Neoplasms | 1 | 2026 | 291 | 0.190 |
Why?
| | Arteriovenous Malformations | 1 | 2022 | 75 | 0.170 |
Why?
| | Kaplan-Meier Estimate | 1 | 2022 | 487 | 0.170 |
Why?
| | Anticonvulsants | 1 | 2022 | 133 | 0.170 |
Why?
| | Melanoma, Experimental | 1 | 2021 | 34 | 0.170 |
Why?
| | Survival Analysis | 1 | 2022 | 659 | 0.170 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2020 | 5 | 0.170 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 89 | 0.160 |
Why?
| | Medicare | 1 | 2022 | 280 | 0.160 |
Why?
| | Primary Cell Culture | 1 | 2020 | 62 | 0.160 |
Why?
| | Hyperalgesia | 1 | 2020 | 39 | 0.160 |
Why?
| | Ganglia, Spinal | 1 | 2020 | 50 | 0.160 |
Why?
| | PC12 Cells | 1 | 2020 | 23 | 0.160 |
Why?
| | Cell Movement | 1 | 2021 | 279 | 0.160 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 50 | 0.160 |
Why?
| | DNA Damage | 1 | 2021 | 309 | 0.150 |
Why?
| | Cell Culture Techniques | 1 | 2020 | 99 | 0.150 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 96 | 0.150 |
Why?
| | Tumor Microenvironment | 1 | 2021 | 274 | 0.150 |
Why?
| | Mice, Transgenic | 1 | 2020 | 561 | 0.150 |
Why?
| | Methionine Adenosyltransferase | 1 | 2018 | 19 | 0.140 |
Why?
| | Internship and Residency | 1 | 2023 | 439 | 0.140 |
Why?
| | Mice, Nude | 1 | 2018 | 232 | 0.140 |
Why?
| | Disease Progression | 1 | 2021 | 880 | 0.140 |
Why?
| | Genetic Loci | 1 | 2018 | 48 | 0.140 |
Why?
| | Caspase 3 | 1 | 2018 | 92 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 630 | 0.140 |
Why?
| | Methionine | 1 | 2018 | 142 | 0.130 |
Why?
| | Radiotherapy Dosage | 3 | 2025 | 249 | 0.130 |
Why?
| | BRCA2 Protein | 1 | 2017 | 19 | 0.130 |
Why?
| | Cell Differentiation | 1 | 2020 | 681 | 0.130 |
Why?
| | Cells, Cultured | 1 | 2020 | 1569 | 0.130 |
Why?
| | Cell Survival | 1 | 2018 | 600 | 0.130 |
Why?
| | Drug Synergism | 1 | 2017 | 147 | 0.130 |
Why?
| | Tumor Burden | 1 | 2017 | 132 | 0.120 |
Why?
| | Mice, SCID | 1 | 2017 | 180 | 0.120 |
Why?
| | Hippocampus | 1 | 2018 | 195 | 0.120 |
Why?
| | Radiation, Ionizing | 1 | 2017 | 101 | 0.120 |
Why?
| | Histones | 1 | 2018 | 318 | 0.120 |
Why?
| | Diet, High-Fat | 1 | 2018 | 243 | 0.120 |
Why?
| | Down-Regulation | 1 | 2017 | 344 | 0.120 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 1003 | 0.110 |
Why?
| | Rats | 1 | 2020 | 3162 | 0.100 |
Why?
| | Retrospective Studies | 2 | 2022 | 6819 | 0.100 |
Why?
| | Lung Neoplasms | 1 | 2018 | 645 | 0.090 |
Why?
| | United States | 1 | 2022 | 5409 | 0.090 |
Why?
| | Neoplasms | 1 | 2021 | 1334 | 0.090 |
Why?
| | Male | 3 | 2020 | 27435 | 0.080 |
Why?
| | Aged | 1 | 2022 | 10429 | 0.070 |
Why?
| | Faculty | 1 | 2023 | 71 | 0.050 |
Why?
| | Educational Status | 1 | 2023 | 229 | 0.050 |
Why?
| | Particle Accelerators | 1 | 2022 | 51 | 0.050 |
Why?
| | Phantoms, Imaging | 1 | 2022 | 112 | 0.040 |
Why?
| | Algorithms | 1 | 2025 | 667 | 0.040 |
Why?
| | Radiometry | 1 | 2022 | 125 | 0.040 |
Why?
| | Uncertainty | 1 | 2018 | 46 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 237 | 0.030 |
Why?
| | Prospective Studies | 1 | 2023 | 2411 | 0.030 |
Why?
|
|
Xia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|